Jeffrey H. Gertsch

Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)

Jeffrey H. Gertsch, Buddha Basnyat, Eric W. Johnson et al. · BMJ · 2004 · 157 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy of Low-dose Acetazolamide (125 mg BID) for the Prophylaxis of Acute Mountain Sickness: A Prospective, Double-blind, Randomized, Placebo-controlled Trial

Buddha Basnyat, Jeffrey H. Gertsch, Eric W. Johnson et al. · High Altitude Medicine & Biology · 2003 · 152 citations

Medicine, Pharmacotherapy, Preventive Medicine +10

Acetazolamide 125 mg BD Is Not Significantly Different from 375 mg BD in the Prevention of Acute Mountain Sickness: The Prophylactic Acetazolamide Dosage Comparison for Efficacy (PACE) Trial

Buddha Basnyat, Jeffrey H. Gertsch, Peter Holck et al. · High Altitude Medicine & Biology · 2006 · 134 citations

Medicine, Pharmacology, Pharmacotherapy +10

Prospective, Double-Blind, Randomized, Placebo-Controlled Comparison of Acetazolamide Versus Ibuprofen for Prophylaxis Against High Altitude Headache: The Headache Evaluation at Altitude Trial (HEAT)

Jeffrey H. Gertsch, Grant S. Lipman, Peter Holck et al. · Wilderness and Environmental Medicine · 2010 · 94 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Ibuprofen Prevents Altitude Illness: A Randomized Controlled Trial for Prevention of Altitude Illness With Nonsteroidal Anti-inflammatories

Grant S. Lipman, Nicholas C. Kanaan, Peter Holck et al. · Annals of Emergency Medicine · 2012 · 92 citations

Medicine, Pharmacology, Pharmacotherapy +11